Search

everythinglearnresearchcommunity

for

Search:↓

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Patients with alopecia areata have lower RBC folate levels, especially in severe cases.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Androgenic alopecia significantly affects adults' quality of life, especially in men and employed individuals.

Vitamin D analogues can significantly help hair regrowth in Alopecia Areata patients.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

AGA patients have a lower quality of life than AA patients.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Bimatoprost may help treat hair loss from alopecia areata.

Oral baricitinib is effective and safe for treating alopecia areata.

Inflammatory diets may increase the risk and severity of alopecia areata.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Alopecia areata affects life quality differently based on its severity.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Different thicknesses of hair strands can indicate the severity of hair thinning.

Targeting IL-15 may help treat Alopecia Areata.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Male gender and family history predict alopecia areata recurrence.